000 01721cam  2200373zi 4500
0019.888456
003CaOODSP
00520231212163049
006m     o  d f      
007cr |n|||||||||
008200622t20202020onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-9/2020-9E-PDF|zH113-9/2020-9E
24500|aFluxapyroxad and Xzemplar.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2020.
264 4|c©2020
300 |a1 online resource (32 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed registration decision, |x1925-0886 ; |vPRD2020-09
500 |aCover title.
500 |a"18 June 2020."
500 |aIssued also in French under title: Fluxapyroxad et produit Xzemplar.
504 |aIncludes bibliographical references (page 32).
520 |a"This Overview describes the key points of the evaluation, while the Science Evaluation section provides detailed technical information on the human health, environmental and value assessments of fluxapyroxad and Xzemplar"--Overview, page 1.
650 0|aFungicides|xCertification|zCanada.
650 0|aFungicides|xToxicology.
650 0|aFungicides|xEnvironmental aspects.
7101 |aCanada. |bPest Management Regulatory Agency, |eissuing body.
77508|tFluxapyroxad et produit Xzemplar.|w(CaOODSP)9.888457
830#0|aProposed registration decision,|x1925-0886 ; |vPRD2020-09.|w(CaOODSP)9.504464
85640|qPDF|s349 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/h113-9/H113-9-2020-9-eng.pdf|z(registration decision)